Kodiak Sciences (KOD) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $58.00 | Aug 17, 2026 |
| JP Morgan | Maintained | Overweight | $66.00 from $56.00 | Aug 3, 2026 |
| Chardan Capital | Upgraded | Neutral → Buy | $61.00 from $14.00 | May 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $58.00 from $38.00 | Mar 27, 2026 |
| UBS | Maintained | Buy | $80.00 from $50.00 | Mar 27, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $38.00 | Feb 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $38.00 from $26.00 | Jan 22, 2026 |
| UBS | Initiated Coverage | Buy | $50.00 | Jan 7, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $26.00 from $24.00 | Nov 17, 2025 |
| Chardan Capital | Maintained | Neutral | $14.00 | Nov 17, 2025 |
| HC Wainwright & Co. | Upgraded | Neutral → Buy | $24.00 from $5.00 | Nov 11, 2025 |
| JP Morgan | Upgraded | Neutral → Overweight | $24.00 from $15.00 | Oct 24, 2025 |
| LifeSci Capital | Initiated Coverage | Outperform | $40.00 | Oct 23, 2025 |
| Chardan Capital | Maintained | Neutral | $14.00 | Oct 6, 2025 |
| Barclays | Upgraded | Underweight → Equal-Weight | $17.00 from $7.00 | Sep 25, 2025 |
| Jefferies | Initiated Coverage | Buy | $15.00 | Sep 22, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | $5.00 from $3.00 | Aug 18, 2025 |
| JP Morgan | Upgraded | Underweight → Neutral | $15.00 | Aug 14, 2025 |
| Barclays | Maintained | Underweight | $7.00 from $4.00 | Aug 14, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | $3.00 | Mar 31, 2025 |
Frequently asked questions
Is KOD a buy, sell, or hold?
Analysts covering Kodiak Sciences currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on KOD?
On Aug 17, 2026, HC Wainwright & Co. maintained Kodiak Sciences at Buy with a price target of $58.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.